• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Improved inference for vaccine-induced immune responses via shape-constrained methods.通过形状约束方法改进对疫苗诱导免疫反应的推断。
Electron J Stat. 2022;16(2):5852-5933. doi: 10.1214/22-ejs2079. Epub 2022 Nov 18.
2
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.南非 HVTN 100 中健康 HIV 阴性成人 12 个月加强免疫后的安全性和免疫应答:ALVAC-HIV(vCP2438)和二价 C 亚型 gp120/MF59 疫苗的随机双盲安慰剂对照试验。
PLoS Med. 2020 Feb 24;17(2):e1003038. doi: 10.1371/journal.pmed.1003038. eCollection 2020 Feb.
3
Semiparametric modelling of two-component mixtures with stochastic dominance.具有随机优势的双组分混合物的半参数建模
Ann Inst Stat Math. 2023;75(1):39-70. doi: 10.1007/s10463-022-00835-5. Epub 2022 May 24.
4
GLOBAL RATES OF CONVERGENCE OF THE MLES OF LOG-CONCAVE AND -CONCAVE DENSITIES.对数凹密度和凹密度极大似然估计的全局收敛速率
Ann Stat. 2016;44(3):954-981. doi: 10.1214/15-AOS1394. Epub 2016 Apr 11.
5
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.抗体和细胞对 HIV 疫苗方案的反应与 DNA 质粒作为佐剂相比:两项随机对照试验分析。
PLoS Med. 2020 May 22;17(5):e1003117. doi: 10.1371/journal.pmed.1003117. eCollection 2020 May.
6
Methods for comparing durability of immune responses between vaccine regimens in early-phase trials.早期临床试验中比较疫苗方案免疫应答持久性的方法。
Stat Methods Med Res. 2020 Jan;29(1):78-93. doi: 10.1177/0962280218820881. Epub 2019 Jan 9.
7
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.C 亚型 ALVAC-HIV 和双价 C 亚型 gp120/MF59 HIV-1 疫苗在南非低危、未感染 HIV 的成年人中的 1/2 期临床试验
Lancet HIV. 2018 Jul;5(7):e366-e378. doi: 10.1016/S2352-3018(18)30071-7. Epub 2018 Jun 18.
8
HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.HIV-1 疫苗序列影响 V1V2 抗体反应:两种痘病毒初免 gp120 加强疫苗方案的比较。
Sci Rep. 2020 Feb 7;10(1):2093. doi: 10.1038/s41598-020-57491-z.
9
Participants' characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa.南非夸祖鲁-纳塔尔省参与者参与 HIV 疫苗和单克隆抗体试验筛查的特征和动机。
Trials. 2021 Dec 11;22(1):897. doi: 10.1186/s13063-021-05792-7.
10
Robust and efficient estimation of GARCH models based on Hellinger distance.基于赫尔利距离的GARCH模型的稳健有效估计
J Appl Stat. 2021 Aug 27;49(15):3976-4002. doi: 10.1080/02664763.2021.1970120. eCollection 2022.

本文引用的文献

1
Immune correlates of the Thai RV144 HIV vaccine regimen in South Africa.南非泰国 RV144 HIV 疫苗方案的免疫相关性。
Sci Transl Med. 2019 Sep 18;11(510). doi: 10.1126/scitranslmed.aax1880.
2
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.C 亚型 ALVAC-HIV 和双价 C 亚型 gp120/MF59 HIV-1 疫苗在南非低危、未感染 HIV 的成年人中的 1/2 期临床试验
Lancet HIV. 2018 Jul;5(7):e366-e378. doi: 10.1016/S2352-3018(18)30071-7. Epub 2018 Jun 18.
3
GLOBAL RATES OF CONVERGENCE OF THE MLES OF LOG-CONCAVE AND -CONCAVE DENSITIES.对数凹密度和凹密度极大似然估计的全局收敛速率
Ann Stat. 2016;44(3):954-981. doi: 10.1214/15-AOS1394. Epub 2016 Apr 11.
4
Benchmarks for detecting 'breakthroughs' in clinical trials: empirical assessment of the probability of large treatment effects using kernel density estimation.临床试验中检测“突破”的基准:使用核密度估计对大治疗效果概率的实证评估。
BMJ Open. 2014 Oct 21;4(10):e005249. doi: 10.1136/bmjopen-2014-005249.
5
Quadratic semiparametric Von Mises calculus.二次半参数冯·米塞斯演算
Metrika. 2009 Mar;69(2-3):227-247. doi: 10.1007/s00184-008-0214-3.
6
Immune-correlates analysis of an HIV-1 vaccine efficacy trial.HIV-1 疫苗功效试验的免疫相关性分析。
N Engl J Med. 2012 Apr 5;366(14):1275-86. doi: 10.1056/NEJMoa1113425.
7
Limit Distribution Theory for Maximum Likelihood Estimation of a Log-Concave Density.对数凹密度最大似然估计的极限分布理论
Ann Stat. 2009 Jun 1;37(3):1299-1331. doi: 10.1214/08-AOS609.
8
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.在泰国使用ALVAC和AIDSVAX疫苗预防HIV-1感染。
N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.
9
Stochastic dominance and medical decision making.
Health Care Manag Sci. 2004 Aug;7(3):207-15. doi: 10.1023/b:hcms.0000039383.54736.65.
10
Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis.净健康效益:成本效益分析中不确定性分析的新框架。
Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S68-80. doi: 10.1177/0272989X98018002S09.

通过形状约束方法改进对疫苗诱导免疫反应的推断。

Improved inference for vaccine-induced immune responses via shape-constrained methods.

作者信息

Laha Nilanjana, Moodie Zoe, Huang Ying, Luedtke Alex

机构信息

Department of Biostatistics, Harvard University, 677 Huntington Ave, Boston, MA 02115, U.S.A.

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.

出版信息

Electron J Stat. 2022;16(2):5852-5933. doi: 10.1214/22-ejs2079. Epub 2022 Nov 18.

DOI:10.1214/22-ejs2079
PMID:37974631
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10653201/
Abstract

We study the performance of shape-constrained methods for evaluating immune response profiles from early-phase vaccine trials. The motivating problem for this work involves quantifying and comparing the IgG binding immune responses to the first and second variable loops (V1V2 region) arising in HVTN 097 and HVTN 100 HIV vaccine trials. We consider unimodal and log-concave shape-constrained methods to compare the immune profiles of the two vaccines, which is reasonable because the data support that the underlying densities of the immune responses could have these shapes. To this end, we develop novel shape-constrained tests of stochastic dominance and shape-constrained plug-in estimators of the squared Hellinger distance between two densities. Our techniques are either tuning parameter free, or rely on only one tuning parameter, but their performance is either better (the tests of stochastic dominance) or comparable with the nonparametric methods (the estimators of the squared Hellinger distance). The minimal dependence on tuning parameters is especially desirable in clinical contexts where analyses must be prespecified and reproducible. Our methods are supported by theoretical results and simulation studies.

摘要

我们研究了形状约束方法在评估早期疫苗试验免疫反应谱方面的性能。这项工作的驱动问题涉及量化和比较在HVTN 097和HVTN 100 HIV疫苗试验中出现的针对第一和第二可变环(V1V2区域)的IgG结合免疫反应。我们考虑使用单峰和对数凹形状约束方法来比较两种疫苗的免疫谱,这是合理的,因为数据表明免疫反应的潜在密度可能具有这些形状。为此,我们开发了新颖的形状约束随机优势检验以及两种密度之间平方Hellinger距离的形状约束插件估计器。我们的技术要么无需调整参数,要么仅依赖一个调整参数,但其性能要么更好(随机优势检验),要么与非参数方法相当(平方Hellinger距离估计器)。在临床环境中,由于分析必须预先指定且可重复,因此对调整参数的最小依赖尤其可取。我们的方法得到了理论结果和模拟研究的支持。